# Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/obinutuzumab-versus-rituximab-for-the-treatment-of-refractory-primary-membranous/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Mingyue Xu,Yifeng Wang,MS Yuejin Wu,Ruiying Chen,Wenqian Zhao,Mingxin Li,Chuan‐Ming Hao,Qionghong Xie |
| Citations | 34 |
| DOI | 10.1093/ndt/gfae230 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4403394225 |
| PMID | 39400696 |
| Type | article |
| Year | 2024 |

## Paper authors

- [Mingyue Xu](https://scholariq.org/researchers/mingyue-xu/)
- [Mingxin Li](https://scholariq.org/researchers/mingxin-li/)
- [Ruiying Chen](https://scholariq.org/researchers/ruiying-chen/)
- [Chuan‐Ming Hao](https://scholariq.org/researchers/chuan-ming-hao/)
- [Qionghong Xie](https://scholariq.org/researchers/qionghong-xie/)

## Paper funders

- [National Natural Science Foundation of China](https://scholariq.org/funders/national-natural-science-foundation-of-china/)
- [Fudan University](https://scholariq.org/funders/fudan-university/)

## Paper journal

- [Nephrology Dialysis Transplantation](https://scholariq.org/journals/nephrology-dialysis-transplantation/)

## Paper primary topic

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)

## Paper topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Pregnancy and Medication Impact](https://scholariq.org/topics/pregnancy-and-medication-impact/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.